
Learning Point of the Article: Denosumab therapy for spinal giant-cell tumor of bone (GCTB)-induced tumor reduction and realignment ofthe vertebral column; however, a long follow-up period is imperative because denosumab does not completely eliminate the GCTB cells. Case Report | Volume 10 | Issue 2 | JOCR March – April 2020 | Page 76-79 | Takafumi Yayama, Kanji Mori, Akira Nakamura, Tomohiro Mimura, Shinji Imai. DOI:...
Read More